Methodological considerations when calculating person time at risk for patients with chronic hepatitis C undergoing antiviral treatment

Methodological considerations when calculating person time at risk for patients with chronic hepatitis C undergoing antiviral treatment

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of hepatology 2017-08, Vol.67 (2), p.427-428
Hauptverfasser: Hallager, Sofie, Ladelund, Steen, Weis, Nina
Format: Artikel
Sprache:eng
Schlagworte:
Antiviral Agents
Gastroenterology and Hepatology
Hepatitis C, Chronic
Humans
Liver Cirrhosis
Sustained Virologic Response
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 428
container_issue 2
container_start_page 427
container_title Journal of hepatology
container_volume 67
creator Hallager, Sofie
Ladelund, Steen
Weis, Nina
description
doi_str_mv 10.1016/j.jhep.2017.02.035
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1891458686</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0168827817302180</els_id><sourcerecordid>1891458686</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-e5ad31f843ddda5029d34a28ddbe062966edc3cdb8e6e6859e49536a06e896d33</originalsourceid><addsrcrecordid>eNp9UsuO1DAQjBCInV34AQ7IRy4JfiQeR0JIaAQL0iIOwNny2D0TZxN7sJ1F-wX8Nh3NwoEDJ1vtqup2VVfVC0YbRpl8PTbjAKeGU7ZtKG-o6B5VGyYprals2eNqgyBVK75VF9VlziOlVNC-fVpdcNWKjop-U_36DGWILk7x6K2ZiI0hewfJFI838nOAQLBulwkr4UhOkHIMpPgZiCkk-XxLDjGREz5DKMjwZSB2SDF4S3A8rBefyY4sAWWPcRUxofg7n7BdSWDKjMRn1ZODmTI8fzivqu8f3n_bfaxvvlx_2r27qW3bdaWGzjjBDji-c850lPdOtIYr5_ZAJe-lBGeFdXsFEqTqemj7TkhDJaheOiGuqldn3VOKPxbIRc8-W5gmEyAuWTPVs7ZTUkmE8jPUpphzgoM-JT-bdK8Z1WsAetRrAHoNQFOuMQAkvXzQX_YzuL-UP44j4M0ZAPjLOw9JZ4vOWXA-gS3aRf9__bf_0O3kwxrdLdxDHuOSAvqnmc5I0F_XFVg3gG0F5UxR8Rv_j6_h</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1891458686</pqid></control><display><type>article</type><title>Methodological considerations when calculating person time at risk for patients with chronic hepatitis C undergoing antiviral treatment</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Hallager, Sofie ; Ladelund, Steen ; Weis, Nina</creator><creatorcontrib>Hallager, Sofie ; Ladelund, Steen ; Weis, Nina</creatorcontrib><identifier>ISSN: 0168-8278</identifier><identifier>EISSN: 1600-0641</identifier><identifier>DOI: 10.1016/j.jhep.2017.02.035</identifier><identifier>PMID: 28435039</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Antiviral Agents ; Gastroenterology and Hepatology ; Hepatitis C, Chronic ; Humans ; Liver Cirrhosis ; Sustained Virologic Response</subject><ispartof>Journal of hepatology, 2017-08, Vol.67 (2), p.427-428</ispartof><rights>European Association for the Study of the Liver</rights><rights>2017 European Association for the Study of the Liver</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-e5ad31f843ddda5029d34a28ddbe062966edc3cdb8e6e6859e49536a06e896d33</citedby><cites>FETCH-LOGICAL-c455t-e5ad31f843ddda5029d34a28ddbe062966edc3cdb8e6e6859e49536a06e896d33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0168827817302180$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28435039$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hallager, Sofie</creatorcontrib><creatorcontrib>Ladelund, Steen</creatorcontrib><creatorcontrib>Weis, Nina</creatorcontrib><title>Methodological considerations when calculating person time at risk for patients with chronic hepatitis C undergoing antiviral treatment</title><title>Journal of hepatology</title><addtitle>J Hepatol</addtitle><subject>Antiviral Agents</subject><subject>Gastroenterology and Hepatology</subject><subject>Hepatitis C, Chronic</subject><subject>Humans</subject><subject>Liver Cirrhosis</subject><subject>Sustained Virologic Response</subject><issn>0168-8278</issn><issn>1600-0641</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UsuO1DAQjBCInV34AQ7IRy4JfiQeR0JIaAQL0iIOwNny2D0TZxN7sJ1F-wX8Nh3NwoEDJ1vtqup2VVfVC0YbRpl8PTbjAKeGU7ZtKG-o6B5VGyYprals2eNqgyBVK75VF9VlziOlVNC-fVpdcNWKjop-U_36DGWILk7x6K2ZiI0hewfJFI838nOAQLBulwkr4UhOkHIMpPgZiCkk-XxLDjGREz5DKMjwZSB2SDF4S3A8rBefyY4sAWWPcRUxofg7n7BdSWDKjMRn1ZODmTI8fzivqu8f3n_bfaxvvlx_2r27qW3bdaWGzjjBDji-c850lPdOtIYr5_ZAJe-lBGeFdXsFEqTqemj7TkhDJaheOiGuqldn3VOKPxbIRc8-W5gmEyAuWTPVs7ZTUkmE8jPUpphzgoM-JT-bdK8Z1WsAetRrAHoNQFOuMQAkvXzQX_YzuL-UP44j4M0ZAPjLOw9JZ4vOWXA-gS3aRf9__bf_0O3kwxrdLdxDHuOSAvqnmc5I0F_XFVg3gG0F5UxR8Rv_j6_h</recordid><startdate>20170801</startdate><enddate>20170801</enddate><creator>Hallager, Sofie</creator><creator>Ladelund, Steen</creator><creator>Weis, Nina</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170801</creationdate><title>Methodological considerations when calculating person time at risk for patients with chronic hepatitis C undergoing antiviral treatment</title><author>Hallager, Sofie ; Ladelund, Steen ; Weis, Nina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-e5ad31f843ddda5029d34a28ddbe062966edc3cdb8e6e6859e49536a06e896d33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Antiviral Agents</topic><topic>Gastroenterology and Hepatology</topic><topic>Hepatitis C, Chronic</topic><topic>Humans</topic><topic>Liver Cirrhosis</topic><topic>Sustained Virologic Response</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hallager, Sofie</creatorcontrib><creatorcontrib>Ladelund, Steen</creatorcontrib><creatorcontrib>Weis, Nina</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hallager, Sofie</au><au>Ladelund, Steen</au><au>Weis, Nina</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Methodological considerations when calculating person time at risk for patients with chronic hepatitis C undergoing antiviral treatment</atitle><jtitle>Journal of hepatology</jtitle><addtitle>J Hepatol</addtitle><date>2017-08-01</date><risdate>2017</risdate><volume>67</volume><issue>2</issue><spage>427</spage><epage>428</epage><pages>427-428</pages><issn>0168-8278</issn><eissn>1600-0641</eissn><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>28435039</pmid><doi>10.1016/j.jhep.2017.02.035</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0168-8278
ispartof Journal of hepatology, 2017-08, Vol.67 (2), p.427-428
issn 0168-8278
1600-0641
language eng
recordid cdi_proquest_miscellaneous_1891458686
source MEDLINE; Elsevier ScienceDirect Journals
subjects Antiviral Agents
Gastroenterology and Hepatology
Hepatitis C, Chronic
Humans
Liver Cirrhosis
Sustained Virologic Response
title Methodological considerations when calculating person time at risk for patients with chronic hepatitis C undergoing antiviral treatment
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T01%3A38%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Methodological%20considerations%20when%20calculating%20person%20time%20at%20risk%20for%20patients%20with%20chronic%20hepatitis%20C%20undergoing%20antiviral%20treatment&rft.jtitle=Journal%20of%20hepatology&rft.au=Hallager,%20Sofie&rft.date=2017-08-01&rft.volume=67&rft.issue=2&rft.spage=427&rft.epage=428&rft.pages=427-428&rft.issn=0168-8278&rft.eissn=1600-0641&rft_id=info:doi/10.1016/j.jhep.2017.02.035&rft_dat=%3Cproquest_cross%3E1891458686%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1891458686&rft_id=info:pmid/28435039&rft_els_id=1_s2_0_S0168827817302180&rfr_iscdi=true